PURE BIOSCIENCE, INC. 8-K

What Happened

• On June 15, 2026, PURE Bioscience, Inc. announced its financial results for the fiscal third quarter ended April 30, 2026 via a press release attached to a Form 8-K. The filing reports Item 2.02 (Results of Operations and Financial Condition) and furnishes the press release as Exhibit 99.1.

Key Details

• Press release date: June 15, 2026.
• Reporting period: fiscal third quarter ended April 30, 2026.
• The press release is furnished as Exhibit 99.1 to the Form 8-K (the exhibit is furnished, not “filed,” and thus not subject to Section 18 liability).
• The Form 8-K also includes the Inline XBRL cover page (Exhibit 104).

Why It Matters

• This filing provides PURE’s latest quarterly results and related financial information (earnings, revenue, and other operating metrics will be in the press release). Retail investors should review the attached press release for the full numbers and any commentary on trends, guidance, or cash position.
• Because the exhibit is furnished rather than filed, investors should follow up with the company’s subsequent periodic filings (e.g., Form 10-Q) for audited or formal financial statements and fuller disclosure.